North America

Anyone remotely optimistic about prospects for global equities over the next 15 years simply cannot avoid, or significantly underweight, US equities.

Concentrating on US healthcare reform has led many analysts to overlook other positives in the biotechnology sector

A diverse range of unconventional assets is available to investors unimpressed by the returns available conventionally

North American fund managers argue that US corporates offer the opportunity to benefit from rapidly growing emerging markets and thereby offer the best of both investment worlds

James Macmillan has joined Gartmore as head of business development for North America. Based in th...